Literature DB >> 24700048

Auditory hallucinations induced by trazodone.

Ippei Shiotsuki1, Takeshi Terao, Nobuyoshi Ishii, Koji Hatano.   

Abstract

A 26-year-old female outpatient presenting with a depressive state suffered from auditory hallucinations at night. Her auditory hallucinations did not respond to blonanserin or paliperidone, but partially responded to risperidone. In view of the possibility that her auditory hallucinations began after starting trazodone, trazodone was discontinued, leading to a complete resolution of her auditory hallucinations. Furthermore, even after risperidone was decreased and discontinued, her auditory hallucinations did not recur. These findings suggest that trazodone may induce auditory hallucinations in some susceptible patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700048      PMCID: PMC3987616          DOI: 10.1136/bcr-2014-203865

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder.

Authors:  Akira Monji; Takahiro Kato; Yoshito Mizoguchi; Hideki Horikawa; Yoshihiro Seki; Shigenobu Kanba
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

2.  Nonantipsychotic therapy for monosymptomatic auditory hallucinations.

Authors:  Joseph M Pierre
Journal:  Biol Psychiatry       Date:  2010-05-26       Impact factor: 13.382

3.  Escitalopram-related visual and auditory hallucination in a non-dementia patient with depression.

Authors:  Chien-Han Lai
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

  3 in total
  1 in total

1.  Case Report: Auditory Hallucination Induced by Amitriptyline for the Treatment of Atypical Odontalgia.

Authors:  Motoko Watanabe; Tetsuo Nakabayashi; Gayatri Nayanar; Chihiro Takao; Chizuko Maeda; Trang Thi Huyen Tu; Haruhiko Motomura; Akira Toyofuku
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.